Xencor Newsroom

Xencor Initiated at Overweight by Wells Fargo

Dow JonesDec 12 22:55

Wells Fargo Initiates Xencor(XNCR.US) With Buy Rating, Announces Target Price $37

Futu NewsDec 12 20:31

CCORF Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $38

Futu NewsDec 10 20:35

Promising Prospects for Xencor's Plamotamab in Autoimmune Treatments Drive Buy Rating

TipRanksDec 10 19:51

Piper Sandler Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $30

Futu NewsDec 6 00:37

Xencor Analyst Ratings

BenzingaDec 2 18:37

Piper Sandler Upgrades Xencor(XNCR.US) to Buy Rating, Raises Target Price to $30

Futu NewsDec 2 18:33

Barclays Maintains Xencor(XNCR.US) With Sell Rating, Maintains Target Price $22

Futu NewsNov 9 19:33

CCORF Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $38

Futu NewsNov 8 22:36

A Quick Look at Today's Ratings for Xencor(XNCR.US), With a Forecast Between $22 to $34

Futu NewsNov 8 21:16

Barclays Sticks to Its Sell Rating for Xencor (XNCR)

TipRanksNov 8 17:53

JP Morgan Maintains Overweight on Xencor, Raises Price Target to $28

BenzingaNov 8 01:57

RBC Capital Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $34

Futu NewsNov 7 20:33

TD Cowen Maintains Xencor(XNCR.US) With Buy Rating

Futu NewsNov 7 08:33

Xencor's Strategic Advancements and Promising Pipeline Drive Buy Rating

TipRanksNov 7 08:07

CCORF Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $38

Futu NewsNov 6 21:31

Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), Argenica Therapeutics Ltd (AU:AGN) and Bio-Rad Laboratories (BIO)

TipRanksOct 8 17:04

Xencor Analyst Ratings

BenzingaSep 26 22:55

RBC Capital Maintains Xencor(XNCR.US) With Buy Rating, Raises Target Price to $34

Futu NewsSep 26 19:33

Xencor (XNCR) Gets a Buy From RBC Capital

TipRanksSep 26 18:59